Barbara McGowan

Once-Weekly Semaglutide in Adults with Overweight or Obesity

John Wilding, Rachel L. Batterham, Salvatore Calanna et al. · New England Journal of Medicine · 2021 · 4.5K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Weight regain and cardiometabolic effects after withdrawal of semaglutide: The <scp>STEP</scp> 1 trial extension

John Wilding, Rachel L. Batterham, Melanie J. Davies et al. · Diabetes Obesity and Metabolism · 2022 · 921 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial

Patrick M. O’Neil, Andreas L. Birkenfeld, Barbara McGowan et al. · The Lancet · 2018 · 804 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

Kisspeptin-54 Stimulates the Hypothalamic-Pituitary Gonadal Axis in Human Males

Waljit S. Dhillo, Owais B. Chaudhri, Michael Patterson et al. · The Journal of Clinical Endocrinology & Metabolism · 2005 · 651 citations · Full text

Medicine, Endocrinology, Pharmacology +14

Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial

David C.W. Lau, Lars Erichsen, Ann Marie Ocampo Francisco et al. · The Lancet · 2021 · 242 citations · Full text

Agriculture, Nutrition, Pharmacotherapy +11